Skip to content

"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake

"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal HPV Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06587243
Enrollment
1100
Registered
2024-09-19
Start date
2025-11-24
Completion date
2027-01-01
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaccination

Keywords

HPV, Vaccine, Narrative, Communication, Videos

Brief summary

This study will compare the use of informational videos only, personal story videos only, and the combination of both, to see which is most effective in increasing HPV vaccination.

Interventions

The informational animation video will also take several minutes and will cover HPV disease, address specific concerns when identified, and the importance and safety of HPV vaccines.

Personal narrative videos will consist of someone describing the person's own personal experience with HPV. The investigators have a collection of videos of personal narratives from different people that the investigators have cut to approximate several minutes in length so the investigators can tailor the personal narratives to match each study participant's race/ethnicity and gender as closely as possible.

Sponsors

Johns Hopkins Bloomberg School of Public Health
Lead SponsorOTHER
Merck Sharp & Dohme LLC
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Parents of 11-17 year olds not yet vaccinated against HPV

Exclusion criteria

* Parents whose adolescent children are already vaccinated against HPV * Participants who do not complete the survey * Participants who are unable or refuse to view and listen to videos on the participant's device

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who receive HPV vaccination9-month follow-upHPV vaccination will be a binary variable (received vs not received)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDaniel Salmon, PhD

Johns Hopkins University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 11, 2026